Evaluation of the clinical efficacy of 3% polydocaol in the treatment of low-flow oral mucosal venous malformation

doi:10.19439/j.sjos.2025.06.016

Abstract

Abstract: PURPOSE: To investigate the clinical efficacy of 3% polidocanol in the treatment of low-flow venous malformations of the oral mucosa. METHODS: A total of 62 patients with low-flow venous malformations of the oral mucosa admitted to the Department of Oral and Maxillofacial Surgery, Affiliated Stomatological Hospital of China Medical University from January to December 2024 were selected. All patients were treated with 3% polidocanol foam sclerotherapy and followed up for 1 to 12 months. The therapeutic effects were evaluated through grade assessment, subjective evaluation by patients, and comparison of photos before and after treatment. RESULTS: Among the 62 patients, 52 were cured (83.87%), 8 showed remarkbally improved, and 2 were improved, with a total effective rate of 100%. The number of treatments ranged from 1 to 3 times, with an average of 1.4 times. Visual analogue scale(VAS) of pain showed that immediate postoperative pain score was 3-8 points, which decreased to 0-1 points after 1 month. Adverse reactions occurred in 8 patients postoperatively, all of them returned to normal after 1 month. CONCLUSIONS: 3% polidocanol is a safe, effective, and low-side-effect treatment for venous malformations of the oral mucosa.

Key words: Venous malformation, Polydocaol, Sclerotherapy, Oral mucosa

CLC Number:

R782.2

Liu Shuang, Sun Ningning, Liu Minda, Dai Wei, Xue Lei, Zhang Enjiao. Evaluation of the clinical efficacy of 3% polydocaol in the treatment of low-flow oral mucosal venous malformation[J]. Shanghai Journal of Stomatology, 2025, 34(6): 647-650.

References

[1] Zheng JW, Mai HM, Zhang L, et al.Guidelines for the treatment of head and neck venous malformations[J]. Int J Clin Exp Med, 2013, 6(5): 377-389.
[2] Zheng JW, Zhou Q, Yang XJ, et al.Treatment guideline for hemangiomas and vascular malformations of the head and neck[J]. Head Neck, 2010, 32(8): 1088-1098.
[3] Judith N, Ulrike E, Siegmar R, et al.Current concepts in diagnosis and treatment of venous malformations[J]. J Craniomaxillofac Surg, 2014, 42(7): 1300-1304.
[4] 王德明, 郑家伟, 苏立新, 等. 静脉畸形中国专家共识[J].介入放射学杂志, 2019, 28(4): 307-311.
[5] 杨耀武, 郑家伟, 范新东, 等. 聚桂醇硬化剂治疗口腔颌面部血管瘤和脉管畸形专家共识[J].中国口腔颌面外科杂志, 2018, 16(3): 275-278.
[6] Rosen RJ, Nassiri N, Drury JE.Interventional management of high-flow vascular malformations[J]. Tech Vasc Interv Radiol, 2013, 16(1): 22-38.
[7] 赵宁, 孙立英, 李云玲, 等. Nd:YAG激光治疗80例口腔黏膜静脉畸形的效果评价[J].上海口腔医学, 2023, 32(2): 166-171.
[8] 周国瑜, 张志愿, 张陈平, 等. 口腔颌面部静脉畸形及血管瘤的激光治疗研究[J].中华口腔医学杂志, 2005, 40(3): 200-202.
[9] Legiehn GM, Heran MKS.Venous malformations: classification, development, diagnosis, and interventional radiologic management[J]. Radiol Clin North Am, 2008, 46(3): 545-597.
[10] Puig S, Casati B, Staudenherz A, et al.Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy[J]. Eur J Radiol, 2005, 53(1): 35-45.
[11] 张志愿,王延安.口腔颌面部脉管性疾病临床诊治[J].中国实用口腔科杂志, 2009, 2(5): 257-260.
[12] Yang X, Chen H, Gu H, et al.Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations[J]. J Vasc Surg Venous Lymphat Disord, 2020, 8(6): 1066-1073.
[13] Weitz-Tuoretmaa A, Keski-Nisula L, Rautio R, et al.Quality of life after endovascular sclerotherapy of low -flow venous malformations: the efficacy of polidocanol compared with ethanol[J]. Acta Radiol, 2018, 59(8): 946-952.
[14] Hou F, Chen J, Xia M, et al.Percutaneous sclerotherapy with polidocanol under the guidance of ultrasound for venous malformations in children-a retrospective cohort study from a single tertiary medical center[J]. Medicine(Baltimore), 2020, 99(9): e18839.

[1]	ZHAO Jiong, BAI Guo, YANG Chi. Single-cell transcriptome characterization of oral mucosal fibroblasts [J]. Shanghai Journal of Stomatology, 2024, 33(1): 1-5.
[2]	YANG Yi-fan, LUO Chun-mei, LI Xiao-bing, DU Qin. Experimental study on the stimulation effect of temperature and capsaicin on oral mucosa of rats [J]. Shanghai Journal of Stomatology, 2023, 32(4): 363-368.
[3]	LI Xiao, FAN Xin-dong, WANG De-ming, YANG Xi-tao, SU Li-xin. Clinical analysis of interventional embolization for 9 cases with frontal arteriovenous malformation [J]. Shanghai Journal of Stomatology, 2023, 32(3): 332-336.
[4]	ZHAO Ning, SUN Li-ying, LI Yun-ling, MA Chuan, CAI Zhen, ZHU Chao. Evaluation of the efficacy of Nd:YAG laser in the treatment of 80 patients with oral mucosal venous malformation [J]. Shanghai Journal of Stomatology, 2023, 32(2): 166-171.
[5]	WANG Xun-xia, JIANG Guo-ping, ZHANG Yong-zhe, LI Ai-qun, WANG Rui-chun. Expression level and clinical significance of CD44 and CD33 in 77 patients with benign lymphoadenosis of oral mucosa [J]. Shanghai Journal of Stomatology, 2023, 32(1): 80-84.
[6]	WU Jing, ZOU Duo-hong, ZHANG Zhi-yuan. The hemostasis effect and cell compatibility of a chitosan-calcium alginate-laponite nanosheet composite membrane: in vitro and in vivo evaluation [J]. Shanghai Journal of Stomatology, 2022, 31(6): 569-575.
[7]	NA Fei, ZHOU Jian-zhong, HE Yong-wen, XIE Zhi-gang, WANG Quan, LI Zi-liang. Pilose antler polypeptide CNT14 promoted proliferation and migration of human oral mucosa fibroblast cells [J]. Shanghai Journal of Stomatology, 2022, 31(6): 607-614.
[8]	ZHOU Yong, ZHOU Zheng-quan, LIU Xue-wei, ZHANG Li-mu, WANG Ye, LIN Xiao-ping. Relationship between peripheral blood micronutrients and four kinds of oral mucosal diseases in children: clinical analysis of 217 cases [J]. Shanghai Journal of Stomatology, 2022, 31(3): 274-281.
[9]	LIU Zhuan-zhuan, XU Na, GAO Rui-fang, ZHANG Fang. Protection effect of baicalin-regulated IKKα on inflammatory reaction of human oral keratinocytes [J]. Shanghai Journal of Stomatology, 2021, 30(6): 589-594.
[10]	LI Jia-peng, ZHANG Guo-run, CHEN Ju-feng, LI Jin, LIU Shi-wei, HE Xian-ming, XIAN Dan. Evaluation of the effectiveness of treatment of 16 patients with tongue microcystic lymphatic malformation using bipolar coagulation forceps combined with 1% lauromacrogol foam sclerotherapy [J]. Shanghai Journal of Stomatology, 2021, 30(4): 444-448.
[11]	LI Jia-peng, XIAN Dan, ZHANG Guo-run, HE Xian-ming, CHEN Ju-feng, LI Jin, ZHANG Guo-yi. DSA types and treatment strategy of venous malformations of the tongue： an analysis of 132 consecutive patients [J]. Shanghai Journal of Stomatology, 2021, 30(2): 145-150.
[12]	LI Dong-yuan, TANG Yun-ju, SHEN Xue-min, ZHANG Wei-qian, XIONG Ping. Application of intraoral ultrasonic imaging in diagnosis and treatment of 18 patients with oral leukoplakia in non-masticatory mucosa [J]. Shanghai Journal of Stomatology, 2020, 29(3): 275-280.
[13]	Society of Oral Medicine Shanghai Stomatological Association, Oral Mucosal Disease Specialist Alliance Organization of Shanghai Ninth People's Hospital Group. Experts recommendation on the diagnosis and treatment of oral mucosal diseases during prevention and control stage of the novel coronavirus infection [J]. Shanghai Journal of Stomatology, 2020, 29(2): 118-122.
[14]	WANG Li-li, LIU Xiang-hong, YANG Lu-ming, LI Xian-xian. Clinical analysis of denture-related oral mucosal lesions in 185 patients with removable denture [J]. Shanghai Journal of Stomatology, 2020, 29(1): 85-88.
[15]	LV Ke-jia, YAN Duo-duo, WANG Guo-hua, YAO Ya-nan, YAO Hua. A primary analysis of oral mucosa and periodontal status of chronic graft-versus-host disease caused by hematopoietic stem cell transplantation [J]. Shanghai Journal of Stomatology, 2018, 27(6): 617-623.